Skip to main content

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 213))

  • 113 Accesses

Abstract

Exertional chest pain, positive exercise test responses and the presence of transient ST segment depression during Holier monitoring strongly suggest the occurrence of myocardial ischemia in syndrome X. However, carefully conducted studies have failed to show: (i) myocardial lactate production during pacing [1,2]; (ii) increases in pulmonary pressure during spontaneous episodes of transient ST segment depression [3]; (iii) abnormalities of left ventricular wall motion as assessed by two-dimensional echocardiography during dipyridamole testing [4]; (iv) decreases in coronary sinus blood oxygen saturation [5] or of pH [6] during atrial pacing; (v) regional perfusion abnormalities during positron emission tomography [7]. Yet, a sizable proportion of patients with syndrome X exhibit an alteration of coronary circulation as suggested by: (i) an abnormally small increase in coronary flow in response to dipyridamole or pacing [8,9], particularly after ergonovine administration [10]; (ii) heterogeneous myocardial perfusion both at rest and during dipyridamole infusion as assessed by positron emission tomography [11,12] and (iii) a regional reduction of thallium uptake during exercise or dipyridamole infusion [13-15].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arbogast R, Bourassa MG. Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms. Comparison with patients having significant coronary artery disease. Am J Cardiol 1973;32:257–263.

    Article  PubMed  CAS  Google Scholar 

  2. Camici PG, Marracini P, Michelassi C, et al. Coronary hemodynamics and myocardial metabolism in patients with Syndrome X. J Am Coll Cardiol 1991; 17:1461–70.

    Article  PubMed  CAS  Google Scholar 

  3. Levy RD, Shapiro LM, Wright C, Mockus L, Fox KM Diurnal variation in left ventricular function: a study of patients with myocardial ischaemia, syndrome X, and of normal controls. Br Heart J 1987; 57:148–53.

    Article  PubMed  CAS  Google Scholar 

  4. Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A. usefulness of a high-dose dipyridamoleechocardiography test for diagnosis of syndrome X. Am J Cardiol 1987; 60;508–12

    Article  PubMed  CAS  Google Scholar 

  5. Crake T, Canepa-Anson R, Shapiro LM, Poole-Wilson PA. Continuos recording of coronary sinus saturation during atrial pacing in patients with and without coronary artery disease or with syndrome X. Br Heart J 1987;57:67–72.

    Google Scholar 

  6. Rosano GMC, Kaski JC, Arie S, et al. Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J 1996;17:1175–80.

    Article  PubMed  CAS  Google Scholar 

  7. Rosen SD, Uren NG, Kaski JC, Tousoulis D, Davies GJ, Camici PG. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation 1994;90:50–60.

    Article  PubMed  CAS  Google Scholar 

  8. Cannon RO III, Watson RM, Rosing DR, Epstein SE. Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1983;1:1359–73.

    Article  PubMed  Google Scholar 

  9. Opherk d, Weihe E, Mall G, et al. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation 1981;63:817–5.

    Article  PubMed  CAS  Google Scholar 

  10. Cannon RO, Schenke WH, Leon MB, Rosing DR, Urqhart J, Epstein SE. Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction. Circulation 1987;75:163–74.

    Article  PubMed  Google Scholar 

  11. Galassi AR, Crea F, Araujo L., et al. Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. Am J Cardiol 1993;72:134–139.

    Article  PubMed  CAS  Google Scholar 

  12. Meeder JG, Blanksma PK, Crijns HGJM, et al. Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J 1995;16:1571–7.

    PubMed  CAS  Google Scholar 

  13. Kaul S, Newell JB, Chesler DA, Pohost GM, Okada RD, Boucher CA: Quantitative thallium imaging findings in patients with normal coronary angiographic findings and in clinically normal subjects. Am J Cardiol 1986; 57:509–12.

    Article  PubMed  CAS  Google Scholar 

  14. Tweddel AC, Martin W, Hutton I: Thallium scan in syndrome X. Br Heart J 1992; 68:48–50.

    Article  PubMed  CAS  Google Scholar 

  15. Korhola O, Valle M, Frick MH, Wiljasalo M, Riihimä KE: Regional myocardial perfusion abnormalities on xenon-133 imaging in patients with angina pectoris and normal coronary arteries. Am J Cardiol 1977; 39:355–9.

    Article  PubMed  CAS  Google Scholar 

  16. Galassi AR, Kaski JC, Crea F, et al. Heart rate response during exercise testing and ambulatory ECG monitoring in patients with syndrome X. Am Heart J 1991;122:458–463.

    Article  PubMed  CAS  Google Scholar 

  17. Rosano GMC, Ponikowski P, Adamopoulos S, Collins P, Poole-Wilson PA, Coats MS, Kaski JC. Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol 1994;73:1174–9.

    Article  PubMed  CAS  Google Scholar 

  18. Rosen SD, Dritsas A, Bourdillon PJ, Camici PG. Analysis of the electrocardiographic QT interval in patients with syndrome X. Am J Cardiol 1994; 971–2.

    Google Scholar 

  19. Tousoulis D, Crake T, Lefroy DC, Galassi AR, Maseri-A. Left ventricular hypercontractility and ST segment depression in patients with syndrome X.

    Google Scholar 

  20. Montorsi P, Fabblocchi F, Loaldi A, et al. Coronary adrenergic hyperreactivity in patients with syndrome X and abnormal electrocardiogram at rest. Am J Cardiol 1991; 68:1698–1703.

    Article  PubMed  CAS  Google Scholar 

  21. Chauhan A, Mullins PA, Petch MC, Schofield PM. Effect of hyperventilation and mental stress on coronary blood flow in syndrome X. Br Heart J 1993;69:516–524.

    Article  PubMed  CAS  Google Scholar 

  22. Rosen SD, Boyd H, Rhodes CG, Kaski JC, Camici PG. Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X. Am J Cardiol 1996;78:37–42.

    Article  PubMed  CAS  Google Scholar 

  23. Sax FL, Cannon RO, Hanson C, Epstein SE. Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalised disorder of vascular function? N Engl J Med 1987;317:1366–1370.

    Article  PubMed  CAS  Google Scholar 

  24. Cannon RO, Cattau EL, Yakshe PN, Maher K, Schenke WH, Benjamin SB, Epstein SE. Coronary flow reserve, esophageal motility, and chest pain in patients with angiographically normal coronary arteries. Am J Med 1990;88:217–222.

    Article  PubMed  Google Scholar 

  25. Cannon RO, Cattau EL, Yakshe PN, Maher K, Schenke WH, Benjamin SB, Epstein SE. Coronary flow reserve, esophageal motility, and chest pain in patients with angiographically normal coronary arteries. Am J Med 1990;88:217–222.

    Article  PubMed  Google Scholar 

  26. Dean JD, Jones CJH, Hutchison SJ, Peters JR, Henderson AH. Hyperinsulinaemia and microvascular angina (“syndrome X”). Lancet 1991;337:456–457.

    Article  PubMed  CAS  Google Scholar 

  27. Becker HE, Moller N, Oyesen P, Mengel A, Schmitz O, Orskov H, Bagger JP. Insulin resistance in microvascular angina (syndrome X). Lancet 1993;342:136–140.

    Article  Google Scholar 

  28. Cannon RO, Quyyumi AA, Schenke WH, et al. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 1990;16:1359–1366.

    Article  PubMed  Google Scholar 

  29. Paseeri V, Lanza GA, Buffon A, Montenero AS, Crea F, Maseri A. Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X. J Am Coll Cardiol 1998;31:62–66.

    Article  Google Scholar 

  30. Maseri A, Crea F, Kaski JC, Crake T. Mechanism of Angina Pectoris in Syndrome X. J Am Coll Cardiol 1991;17:499–506.

    Article  PubMed  CAS  Google Scholar 

  31. Gutteridge JMC, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. TIBS 1990; 15:129–135.

    PubMed  CAS  Google Scholar 

  32. Saran M, Bors W. Radical reaction in vivo - an overview. Radiation and Environmental Biophisics 1990; 29:249–262.

    Article  CAS  Google Scholar 

  33. Buffon A, Santini SA, Rigattieri S, Ramazzotti V, Summaria F, Mordente A, Liuzzo G, Biasucci LM, Crea F, Maseri A. Myocardial lipid peroxidation caused by successful coronary angioplasty. Circulation 1997; 96(Supp1.I):756.

    Google Scholar 

  34. Buffon A, Santini SA, Rigattieri S, Ramazzotti V, Summaria F, Mordente A, Liuzzo G, Biasucci LM, Crea F, Maseri A. Transient intracardiac lipid peroxidation induced by atrial pacing in syndrome X: a definitive demonstration of an ischemic mechanism?. Circulation 1997; 96(Suppl.I):761.

    Google Scholar 

  35. K. Myung-Suk, Akera T. O2 free radicals: cause of ischemia-reperfusion injury to cardiac Na+-K+-ATPase. Am J Physiol 1987; 252:H252–H257.

    Google Scholar 

  36. Wafelman AR, Hoefnagel CA, Maes RAA, Beijnen JH. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions and dosimetry. Eur J Nucl Med 1994;21:545–559.

    Article  PubMed  CAS  Google Scholar 

  37. Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland TM, Glowniak JV, Sherman P, Beierwaltes WH. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987;28:1625–36.

    PubMed  CAS  Google Scholar 

  38. Wieland TM, Brown LE, Rogers L, Worthington KC, Wu J, Clinthome NH, Otto CA, Swanson DP, Baierwaltes WH. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22–31.

    PubMed  CAS  Google Scholar 

  39. Lanza GA, Giordano AG, Pristipino C, et al. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy. Circulation 1997;96:821–6.

    Article  PubMed  CAS  Google Scholar 

  40. Wieland TM, Brown LE, Rogers L, Worthington KC, Wu J, Clinthorne NH, Otto CA, Swanson DP, Baierwaltes WH. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981;22:22–31.

    PubMed  CAS  Google Scholar 

  41. Dae MW, Herre JM, O’Connell JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol 1991;17:1416–23.

    Article  PubMed  CAS  Google Scholar 

  42. Tomoda H, Yoshioka K, Shiina Y, Tagawa R, Ide M, Suzuki Y. Regional sympathetic denervation detected by iodine 123 metaiodobenzylguanidine in non-Q-wave myocardial infarction and unstable angina. Am Heart J 1994;128:452–8.

    Article  PubMed  CAS  Google Scholar 

  43. Hartikainen J, Kuikka J, Mantysaari M, Lansimies E, Pyorala K. Sympathetic reinnervation after acute myocardial infarction. Am J Cardiol 1996;77:5–9.

    Article  PubMed  CAS  Google Scholar 

  44. De Marco T, Dae M, Yuen-Gree MSF, Kumar S, Sudhir K, Keith F, Amidon TM, Rifkin C, Klinski C, Lau D, Botvinick EH, Chatterjee K. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol 1995;25:927–31.

    Article  PubMed  Google Scholar 

  45. Nakajo M, Shimabukuro K, Yoshimura H, Yonekura R, Nakabeppu Y, Tanoue P, Shinohara S. Iodine-131 metaiodobenzylguanidine intra-and extravascular accumulation in the rat heart. J Nucl Med 1986;27:84–89.

    PubMed  CAS  Google Scholar 

  46. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, Fukuyama T. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous acitivity in congestive heart failure independent of underlying cause. J Am Coll Cardiol 1995;26:1594–9.

    Article  PubMed  CAS  Google Scholar 

  47. Tsutsui H, Ando S, Fukai T, Kuroiwa M, Egashira K, Sasaki M, Kuwabara Y, Koyanagi S, Takeshita A. Detection of angina-provoking coronary stenosis by resting iodine 123 metaiodobenzylguanidine scintigraphy in patients with unstable angina pectoris. Am Heart J 1995;129:708–15.

    Article  PubMed  CAS  Google Scholar 

  48. Nakata T, Nagao K, Tsuchihashi K, Hashimoto A, Tanaka S, Iimura O. Regional cardiac sympathetic nerve dysfunction and the duagnostic efficacy of metaiodobenzylguanidine in stable coronary artery disease. Am J Cardiol 1996;78:292–7.

    Article  PubMed  CAS  Google Scholar 

  49. Takano H, Nakamura T, Satou T, Umetani K, Watanabe A, Ishihara T, Mochizuchi S, Kimura H, Honma H, Ikeda Y, Koizumi K, Arbab AS, Tamura K. Regional myocardial sympathetic dysinnervation in patients with coronary vasospasm. Am J Cardiol 1995;75:324–29.

    Article  PubMed  CAS  Google Scholar 

  50. Canessa M. Erythrocyte sodium-lithium countertransport: another link between essential hypertension and diabetes. Cuff Opin Nephrol Hypertens 1994;3(5):511–517.

    Article  CAS  Google Scholar 

  51. Kahn AM, Allen JC, Cragoe EG Jr, Shelat H. Sodium-lithium exchange and sodium-proton exchange are mediated by the same transport system in sarcolemmal vescicles from bovine superior mesenteric artery. Circ Res 1989;65:818–828.

    Article  PubMed  CAS  Google Scholar 

  52. Rosskopf D, Dusing R, Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension 1993;21:607–617.

    Article  PubMed  CAS  Google Scholar 

  53. Gaspardone A, Ferri C, Crea F, et al. Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: a potential link between cardiac and metabolic syndrome X. J Am Coll Cardiol (in press).

    Google Scholar 

  54. Koren W, Koldanov R, Peleg E, Rabinowitz B, Rosenthal T. Enhanced red cell sodium-hydrogen exchange in microvascular angina. Eur Heart J. 1997;18:1296–1299.

    Article  PubMed  CAS  Google Scholar 

  55. Gaspardone A, Ferri C, Crea F, et al. Red blood cell Na+/K+ ATPase and Na+/K+/2CI- countertransport activity in patients with syndrome X (Abstr). Eur Heart J (in press).

    Google Scholar 

  56. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol 1977;232:C165–C173.

    PubMed  CAS  Google Scholar 

  57. Rosskopf D, Dusing R, Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension 1993;21:607–617.

    Article  PubMed  CAS  Google Scholar 

  58. Aviv A. The role of Ca2+ protein kinase C, and the Na+-H+ antiport in the development of hypertension and insulin resistance. J Am Soc Nephrol. 1992;3(5):1049–1063.

    PubMed  CAS  Google Scholar 

  59. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelimdependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659–1664.

    Article  PubMed  CAS  Google Scholar 

  60. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246–2252.

    Article  PubMed  CAS  Google Scholar 

  61. Camici PG, Marraccini P, Gistri R, Salvadori PA, Sorace O, L’Abbate A. Adrenergically mediated coronary vasoconstriction in patients with syndrome X. Cardiovasc Drugs Ther 1994;8:221–226.

    Article  PubMed  CAS  Google Scholar 

  62. Ungerer M, Chlistalla A, Karoglan M, Richardt G. Regulation of cardiac uptake 1 by intra-and extraneural norepinephrine, and by transmembranous sodium gradient. Circulation 1996;94:I-128.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Crea, F., Buffon, A., Gaspardone, A., Lanza, G. (1999). Alternative Mechanisms for Myocardial Ischemia in Syndrome X - New Diagnostic Markers. In: Kaski, J.C. (eds) Chest Pain with Normal Coronary Angiograms: Pathogenesis, Diagnosis and Management. Developments in Cardiovascular Medicine, vol 213. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5181-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5181-2_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7360-5

  • Online ISBN: 978-1-4615-5181-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics